1) Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992;326:1473-9.
2) Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res 2010;468:2715-24.
3) Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995;77:459-74.
4) Hadjigeorgiou G, Dardiotis E, Dardioti M, et al. Genetic association studies in osteonecrosis of the femoral head:mini review of the literature. Skeletal Radiol 2008;37:1-7.
5) Karol SE, Yang W, Van Driest SL, et al. Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood 2015;126:1770-6.
6) Karol SE, Mattano LA Jr, Yang W, et al. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia. Blood 2016;127:558-64.
7) Baek SH, Kim KI, Yoon KS, et al:Genome-wide association scans for idiopathic osteonecrosis of the femoral head in a Korean population. Mol Med Rep 2017;15:750-8.
8) Sakamoto Y, Yamamoto T, Sugano N, et al. Genome-wide association study of idiopathic osteonecrosis of the femoral head. Sci Rep 2017;7:15035.
9) Oinuma K, Harada Y, Nawata Y, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis 2001;60:1145-8.
10) Kuroda T, Tanabe N, Wakamatsu A, et al. High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus. Clin Rheumatol 2015;34:2071-7.
11) Masada T, Iwakiri K, Oda Y, et al. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res 2008;26:91-5.
12) Takeuchi F, Isono M, Nabika T, et al. Confirmation of ALDH2 as a major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population. Circ J 2011;75:911-8.